As a corollary, we further propose that the conservation of the chemical properties of the first three amino acids on the carboxyterminal side of the SPP cleavage site may also be critical for the efficient processing of the DSPP’s signal peptide (as is the case for many other proteases in biology). The first two amino acids of the mature protein (immediately after the SPP cleavage site) are normally encoded by the last six bases of exon 2 and the third by the first three bases of exon 3. These three amino acids in DSPP are Ile Pro Val (IPV), with the unique and structurally confined proline being flanked by two hydrophobic amino acids. With the exception of a chemically similar Val substituting for the Ile in the elephant, this tripeptide sequence is, to our knowledge, invariant within all animal species sequenced to date (University of California, Santa Clara (UCSC) Genome Bioinformatics; http://genome.ucsc.edu). The chemically similar motif is also found at the SPP cleavage site in several of the other major human proteins secreted during tooth matrix assembly, including: DMP1 (LeuProVal), OPN (LeuProVal), ameloblastin (ValProPhe), and amelogenin (MetProLeu). This completely conserved Pro in DSPP was shown to be mutated to a serine (p.P17S) in our single representative of the Brandywine DGI family (Family DGI-1), a result identical to that recently reported for a different kindred by , and similar to the p.P17 T first noted by . These changes may cause signal peptide processing errors by the odontoblast SPP and result in dominant dentin diseases similar to that seen in direct changes in the signal peptide. At first, the change of the mature protein’s third position, Val, in the p.V18F (c.52G4T) event [; ; ; ] looks to be just a chemically conserved missense mutation unlikely to cause significant changes in the processing of DSPP. However, we propose that this represents the first in a series of splice-site mutations involving exon 3. The consensus sequence derived for the underlying DNA of the mRNA’s splice donors and acceptors is shown in . The GT and AG ends of the intronic sequence are nearly invariant, although GT and AG are common dinucleotide sequences. Therefore, the likelihood of a splice event occurring at any particular GT (GU in the RNA transcript itself) or AG increases as the sequences better fit the consensus. Using the SplicePort program (http://spliceport.cs.umd.edu), the p.V18F mutation changes the functional (10.91) splice acceptor site: CAG^GTT(Val) into a sequence predicted to be ineffective, CAG^TTT(Phe) (−0.02; see ) []. Due to the lack of a strong alternative splice acceptor site within 50 bp of the damaged one [], the loss of this spice junction would likely cause exon 3 to be skipped, bringing exon 4 (with its normal splice acceptor, CAG^GAT) in-frame to exon 2. This would make the carboxy-terminal side of the SPP cleavage site become Ile Pro Asp, thereby replacing the highly conserved hydrophobic Val with a very hydrophilic amino acid, aspartic acid. Our splice-site mutation in Patient DGI-7, as well as all of the previously published splice junction mutations (), will result in this same loss of exon 3 and consequent replacement of the hydrophobic Val with a hydrophilic Asp. Even the published nonsense mutation pQ45X [; ] can logically be hypothesized to frequently result in the loss of exon 3. The normal splice donor site for exon 3 (including the CAG codon for glutamine, which is conserved in all known species) is CAG^GT, but the transition event makes it TAG^GT, thereby changing a comparatively weak donor site (10.94) into a predicted less functional site (10.39; see ) that may cause exon 3 to be skipped at least some of the time. Using neural network–based splice-site recognition programs in the study of human disease-causing splice junction mutations, noted that many disease-causing mutations were the result of changes in donor splice-sites that were already suboptimal. Thus, all of the early exon missense, nonsense, and splice junction mutations can be hypothesized to be dominant due to errors of signal peptide (or subsequent IPV-dependent) processing events that may, in turn, result in the normal DSPP protein, collagen, or other critical proteins not being properly processed for the rapidly accumulating dentin matrix.